Profile picture of Immunocore

Immunocore

Abingdon, United Kingdom
2 staff members
4 29 Reviews
Company Profile

Based in Abingdon (UK) and Philadelphia (USA) we're a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. Our world-leading T cell receptor technology exploits the power of the body?s own immune system to find and kill diseased cells. We've established a robust technology platform which combines monoclonal T cell receptor (mTCR) targeting technology with an effector technology, anti-CD3 scFv, that catalyses the killing of the targeted diseased cells by the host?s own non-specific cytotoxic T cells. And we're developing a portfolio of products from the platform, called ImmTACs, for the treatment of cancer, chronic infectious disease and diabetes.

Company size

201 to 500 Employees

Type

Company - Private

Revenue

Unknown / Non-Applicable

Industry

Biotech & Pharmaceuticals

Competitors

?Immatics Biotechnologies, Adaptimmune

Founded

2008

Share Profile

Staff Members
avatar
CEO
0.0
Worked since Sunday, Jun 15 2025
People Also Viewed
  • logo
    Wilsonville, OR
    2.5
    Company size: 51 to 200
  • logo
    Crumlin, Wales (UK)
    2.5
    Company size: 201 to 500
  • logo
    Holmdel, NJ
    2.5
    Company size: 1 to 50
  • logo
    Kennesaw, GA (US)
    2.5
    Company size: 51 to 200
  • logo
    Medford, MA
    2.5
    Company size: 201 to 500
  • logo
    New York, NY
    2.5
    Company size: 51 to 200